Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure-response analysis.
about
Quantitative Prediction of the Effect of CYP3A Inhibitors and Inducers on Venetoclax Pharmacokinetics Using a Physiologically Based Pharmacokinetic Model.Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma.Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Chronic Lymphocytic Leukemia: Ibrutinib, Idelalisib, and Venetoclax.Clinical evaluation of P-glycoprotein inhibition by venetoclax: a drug interaction study with digoxin.Pharmacokinetics of the BCL-2 Inhibitor Venetoclax in Healthy Chinese Subjects.Exposure-response evaluations of venetoclax efficacy and safety in patients with non-Hodgkin lymphoma.Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics.Venetoclax: A novel B-cell lymphoma-2 inhibitor for chronic lymphocytic leukemia and other hematologic malignancies.
P2860
Q39040977-E88515F7-72C4-4C50-A20A-41576517CA3EQ39177442-A09C5BC8-94C8-4E59-AA67-C0FA6CD725F8Q39200835-F6AFBA67-06C5-471E-9F7D-CA12DD98A71DQ47610956-A2B5E144-AFA8-4EB6-8216-17AFD0644DE1Q48146110-CFA3FC81-CB16-4D74-AC10-B2DE89DE280BQ48257454-3F259D56-54CC-4EF2-9083-8A41509BB8C7Q50119590-7E904E15-B8CD-43D6-B3C8-2ED3EFC0ECE8Q51842580-AE31D00B-BDA9-461C-99FF-AB4A65DB4788
P2860
Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure-response analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Venetoclax does not prolong th ...... an exposure-response analysis.
@en
type
label
Venetoclax does not prolong th ...... an exposure-response analysis.
@en
prefLabel
Venetoclax does not prolong th ...... an exposure-response analysis.
@en
P2093
P2860
P1476
Venetoclax does not prolong th ...... an exposure-response analysis
@en
P2093
Aksana K Jones
David Hoffman
Kevin J Freise
Martin Dunbar
Sari L Heitner Enschede
Shekman Wong
P2860
P2888
P304
P356
10.1007/S00280-016-3144-1
P577
2016-09-01T00:00:00Z
P6179
1027208212